Breaking News

PSL Opens New Office in Australia

By Kristin Brooks | February 27, 2014

Landais to head Asia-Pacific region

PSL has opened its new office in Australia to serve customers in the Asia Pacific region (excluding India). Pierre Landais will head PSL Australia serving as tendering manager, Asia-Pacific. Mr. Landais joined the company in 2009 as a graduate project manager and most recently served as technical sales manager based in PSL France.
 
He will support and serve new and existing customers with advanced process requirements, and also provide real-time support to PSL’s local partners and distribution network throughout the region, including Nara Machinery in Japan. PSL has manufacturing facilities for the production of high potency drugs, and offers expertise designing and engineering advanced containment processes for the manufacture of sterile, oncology, hormone and many other pharmaceutical compounds.
 
"PSL has been supporting the Asian markets for two decades with leading edge technologies supplied to blue chip pharma groups in South East Asia accounting for more than 60 installations in Singapore alone,” said Remy Wattiaux, managing director of PSL.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important